“Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies” (2020) SKIN The Journal of Cutaneous Medicine, 4(5), p. s55. doi:10.25251/skin.4.supp.54.